The global Blood Culture Tests Marketwas valued at USD 3,251.63 million in 2016 and is projected to reach USD 6,254.92 million by 2025, growing at a CAGR of 7.54% from 2017 to 2025.
Blood cultures are used to detect the presence of bacteria or fungi in the blood, to identify the type present, and to guide treatment. Testing is used to identify a blood infection (septicemia) that can lead to sepsis, a serious and life-threatening complication.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing cases of sepsis cases
1.2 GrowingGeriatric Population
1.3 Increasing research and product launches
1.4 Increasing incidences of Bloodstream infections
1.5 Demand for Rapid and Efficient diagnostics
1.6 High number of infections and disease spreads
2. Market Restraints
2.1 High cost of equipment
2.2 Lack of Trained technicians
Market Segmentation:
1. Global Blood Culture Tests Market, by Application:
1.1 Bacteremia
1.2 Fungemia
1.3 Mycobacterial Detection
2. Global Blood Culture Tests Market, by Technology:
2.1 Proteomics Technology
2.2 Culture-Based Technology
3. Global Blood Culture Tests Market, by Method:
3.1 Conventional/Manual Methods
3.2 Automated Methods
3.3 Molecular Technologies
3.3.1 Microarrays
3.3.2 PCR (Polymerase Chain Reaction)
3.3.3 PNA-FiSH (Peptide Nucleic Acid â€" Fluroscent in Situ
4. Global Blood Culture Tests Market, byEnd User:
4.1 Hospital Laboratories
4.2 Reference Laboratories
4.3 Academic Research Laboratories
4.4 Other Laboratories
5. Global Blood Culture Tests Market, byProduct:
5.1 Consumables
5.1.1 Assay Kits & Reagents
5.1.2 Blood Culture Accessories
5.1.3 Blood culture Media
5.1.3.1 Aerobic Blood Culture Media
5.1.3.2 Pediatric Aerobic Blood Culture Media
5.1.3.3 Anaerobic Blood Culture Media
5.1.3.4 Mycobacterial Blood Culture Media
5.1.3.5 Fungi/Yeast Blood Culture Media
5.2 Instruments
5.2.1 Supporting Laboratory Equipment
5.2.1.1 Incubators
5.2.1.2 Colony Counters
5.2.1.3 Microscopes
5.2.1.4 Gram Stainers
5.2.2 Automated Blood Culture Systems
5.3 Software and Services
6. Global Blood Culture Tests Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Becton, Dickinson and Company
2. Biomérieux SA
3. Thermo Fisher Scientific, Inc.
4. Cepheid
5. Nanosphere, Inc.
6. Bruker Corporation
7. Beckman Coulter (Wholly Owned Subsidiary of Danaher Corporation)
8. Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
9. Iridica (A Subsidiary of Abbott Laboratories)
10. T2 Biosystems
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Blood Culture Tests Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BLOOD CULTURE TESTS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL BLOOD CULTURE TESTS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 Global Blood Culture Tests Market, by Application:
5.1 Bacteremia
5.2 Fungemia
5.3 Mycobacterial Detection
6 Global Blood Culture Tests Market, by Technology:
6.1 Proteomics Technology
6.2 Culture-Based Technology
7 Global Blood Culture Tests Market, by Method:
7.1 Conventional/Manual Methods
7.2 Automated Methods
7.3 Molecular Technologies
7.3.1 Microarrays
7.3.2 PCR (Polymerase Chain Reaction)
7.3.3 PNA-FiSH (Peptide Nucleic Acid â€" Fluroscent in Situ
8 Global Blood Culture Tests Market, byEnd User:
8.1 Hospital Laboratories
8.2 Reference Laboratories
8.3 Academic Research Laboratories
8.4 Other Laboratories
9 Global Blood Culture Tests Market, byProduct:
9.1 Consumables
9.1.1 Assay Kits & Reagents
9.1.2 Blood Culture Accessories
9.1.3 Blood culture Media
9.1.3.1 Aerobic Blood Culture Media
9.1.3.2 Pediatric Aerobic Blood Culture Media
9.1.3.3 Anaerobic Blood Culture Media
9.1.3.4 Mycobacterial Blood Culture Media
9.1.3.5 Fungi/Yeast Blood Culture Media
9.2 Instruments
9.2.1 Supporting Laboratory Equipment
9.2.1.1 Incubators
9.2.1.2 Colony Counters
9.2.1.3 Microscopes
9.2.1.4 Gram Stainers
9.2.1.5 Automated Blood Culture Systems
9.3 Software and Services
10 GLOBAL BLOOD CULTURE TESTS MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 â€" 2025
11 GLOBAL BLOOD CULTURE TESTS MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Becton, Dickinson and Company
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Biomérieux SA
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Thermo Fisher Scientific, Inc.
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Cepheid
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Nanosphere, Inc.
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Bruker Corporation
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Beckman Coulter
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Roche Diagnostics
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Iridica
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 T2 Biosystems
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
13 Appendix
13.1 Related Reports
The GMP Cell Culture Custom Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Cell Culture And Expansion Technologies Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...
The Culture Transformation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Blood Bank Information System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
Market Overview
The Asia Pacific Vital Sign Monitoring Devices Market is set to experience significant expansion from 2024 to 2034. This growth is driven by the increasing prevalence of chronic diseases, rising health awareness, and advancements in monitoring technology. The market is p...
Market Overview
The Europe Vital Sign Monitoring Devices Market is projected to witness significant growth from 2024 to 2034, driven by increasing demand for continuous health monitoring, rising prevalence of chronic diseases, and the expanding elderly population. The market is anticipa...
Market Overview
The North America Vital Sign Monitoring Devices Market is anticipated to witness robust growth between 2024 and 2034, driven by an increasing prevalence of chronic diseases, rising health awareness, and the growing adoption of remote patient monitoring technologies. The ...
Market Overview
The Global Vital Sign Monitoring Devices Market is anticipated to experience significant growth from 2024 to 2034, driven by technological advancements, increasing prevalence of chronic diseases, and the growing demand for home healthcare solutions. Valued at USD XX.XX b...
Market Overview
The Asia Pacific Ambulance Equipment Market is poised for substantial growth from 2024 to 2034, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and advancements in medical technology. The market is projected to reach a valuation of US...
Market Overview
The Europe Ambulance Equipment Market is projected to experience substantial growth over the next decade, driven by advancements in medical technology, increasing healthcare expenditure, and the rising incidence of chronic diseases and medical emergencies. The market is ...